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Abstract
Background: Continuous renal replacement therapy (CRRT) is essential in the management of critically ill patients
with acute kidney injury (AKI). However, the optimal timing for initiating CRRT remains controversial, especially in
elderly patients. Therefore, we investigated the outcomes of early CRRT initiation in elderly patients with AKI.
Methods: A total of 607 patients ≥65 years of age who started CRRT due to AKI between August 2009 and
December 2013 were prospectively enrolled. They were divided into two groups based on the median 6-hour urine
output immediately before CRRT initiation. Propensity score matching was used to compare the overall survival
rate, CRRT duration, and hospitalization duration.
Results: The median age of both groups was 73.0 years, and 60 % of the patients were male. The most common
cause of AKI was sepsis. In the early CRRT group, the mean arterial pressure was higher, but the prothrombin time
and total bilirubin, aspartate aminotransferase, and alanine aminotransferase levels were lower. The overall
cumulative survival rate was higher in the early CRRT group (log-rank P < 0.01). Late CRRT initiation was associated
with a higher mortality rate than early initiation after adjusting for age, sex, the Charlson comorbidity index, systolic
arterial pressure, prothrombin time, the total bilirubin, aspartate aminotransferase, and alanine aminotransferase
levels, cumulative fluid balance and diuretic use (hazard ratio, 1.35; 95 % confidence interval 1.06, 1.71, P = 0.02).
Following propensity score matching, patient survival was significantly better in the early CRRT group than in the
late CRRT group (P < 0.01). The total duration of hospitalization from the start of CRRT was shorter among the
survivors when CRRT was started earlier (26.7 versus 39.1 days, P = 0.04).
Conclusion: A better prognosis can be expected if CRRT is applied early in the course of AKI in critically ill,
elderly patients.
Keywords: Elderly patients, Survival, Continuous renal replacement therapy, Acute kidney injury, Propensity
score matching
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Background
Elderly people (aged ≥65 years) are currently the fastest-
growing sector of the general population in developed
countries. They are more prone to developing acute kid-
ney injury (AKI) because of structural and functional
alterations in the kidney [1, 2], comorbidities (e.g., ar-
teriosclerosis, hypertension, diabetes mellitus, and heart
failure), and polypharmacy for the treatment of comor-
bidities, which increase in prevalence with age. Accord-
ingly, an increasing number of elderly patients can be
expected to develop AKI [3–5].
For more than a decade, continuous renal replacement
therapy (CRRT) has been essential in the management
of critically ill patients with AKI [6, 7]. The generally ac-
cepted indications for initiating CRRT in AKI include
persistent hyperkalemia, severe acidosis and hypervole-
mia that are unresponsive to adequate medical manage-
ment, and overt uremic symptoms or signs (e.g., uremic
bleeding, pericarditis, and encephalopathy) [8–10].
Although the optimal timing of CRRT initiation re-
mains controversial, recent studies comparing early and
late initiation have suggested that early initiation may
have a beneficial impact on survival [11–14]. However,
elderly patients are more susceptible to hemodynamic
complications during dialysis, such as intradialytic
hypotension and arrhythmia, because of decreased
autonomic function and cardiovascular reserve, bleed-
ing problems, and neurological complications result-
ing from rapid changes in serum electrolytes and
osmolarity [15, 16]. Additionally, because short-term
and long-term survival following CRRT are expected
to be lower in elderly patients compared with the
general population [17], therapeutic decisions, includ-
ing use of CRRT, tend to be more conservative for
patients in this age group, especially in intensive care.
Nevertheless, few studies have specifically examined
CRRT in older individuals with AKI. Therefore, although
previous studies have demonstrated that early initiation of
CRRT could be beneficial in the general population, it is
not clear whether it could also benefit elderly patients.
In the present study, we aimed to investigate the out-
comes of early versus late initiation of CRRT using
propensity score matching (PSM) in a multicenter, pro-
spective CRRT cohort of elderly individuals.
Methods
Study population
All patients aged ≥18 years who received CRRT for AKI
at Seoul National University Hospital, Seoul National
University Boramae Hospital, and Yonsei University
Severance Hospital were initially screened (n = 1471).
The patients were prospectively enrolled between August
2009 and December 2013. We excluded 724 patients who
were younger than 65 years of age and 140 who were on
chronic dialysis. A total of 607 patients were included in
the analyses. They were divided into two groups based on
the body-weight-adjusted median 6-h urine output imme-
diately before administration of CRRT.
Definitions
The definition of AKI was based on the Kidney Disease:
Improving Global Outcomes (KDIGO) clinical practice
guidelines for AKI and was defined as the presence of at
least one of the following criteria: an increase in the
serum creatinine level ≥0.3 mg/dL (≥26.5 μmol/L) within
48 h; an increase in the serum creatinine level to ≥1.5
times the baseline level that was known or was pre-
sumed to have occurred within the previous 7 days; or
urine volume <0.5 mL/kg/h for 6 h. For the diagnosis of
systemic inflammatory response syndrome, the presence
of at least two of the following criteria were required:
core temperature ≥38 °C or ≤36 °C; heart rate ≥90 beats
per minute; respiratory rate ≥20 breaths per minute and
PCO2 ≤ 32 mmHg or mechanical ventilation; and periph-
eral leukocyte count ≥12,000/mm3 or ≤4000/mm3 [18].
Septic AKI was defined as systemic inflammatory re-
sponse syndrome combined with an infectious episode
and AKI.
Clinical outcomes
The primary outcome was the patient survival rate after
CRRT initiation. The secondary outcomes were mortal-
ity on the 28th day of CRRT, the durations of CRRT and
total renal replacement therapy (RRT), and the durations
of total hospitalization and stay in the intensive care unit
(ICU) from CRRT initiation.
Data collection
At the time of CRRT initiation, demographic, clinical,
and laboratory data were collected. For the assessment
of disease severity, the Charlson comorbidity index
(CCI), sequential organ failure assessment (SOFA) score,
and acute physiology and chronic health evaluation
(APACHE) II score were calculated at the time of dialy-
sis initiation [19, 20]. All available intake and output
data for 3 days immediately before CRRT initiation were
used to calculate the cumulative fluid balance. The esti-
mated glomerular filtration rate (eGFR) was also calcu-
lated using the modification of diet in renal disease
equation [21]. The patients were stratified into two
groups (patients with early or late CRRT) based on the
body-weight-adjusted median 6-h urine output before
CRRT initiation.
Statistical analysis
Categorical variables described as frequencies and pro-
portions were compared using the chi-squared test. Fol-
lowing a test for normality, the non-normally distributed
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variables were expressed as the median (25–75th percen-
tiles) and were compared using the Mann–Whitney
U or Kruskal-Wallis test. The normally distributed
variables were presented as the mean ± standard deviation.
Patient survival was estimated by Kaplan-Meier curves
and multivariate Cox regression models based on the
body-weight-adjusted median 6-h urine output immedi-
ately before CRRT initiation. Propensity scores were esti-
mated by multiple logistic regression analysis with
adjustments for patient age, sex, the CCI, systolic arterial
pressure, prothrombin time, and the total bilirubin level.
After calculation of the propensity scores, we matched pa-
tients in the early and late CRRT groups with similar pro-
pensity scores at a 1:1 ratio using the nearest neighbor
method, no replacement, and a 0.2 caliper width. PSM
was used to increase the precision of the estimated effect
without increasing bias due to the presence of variables
potentially associated with survival [22]. The characteris-
tics of both the early and late CRRT groups were com-
pared before and after PSM. Kaplan-Meier survival curves
and life tables were generated for the two groups after
PSM.
All statistical tests were evaluated using a two-tailed
95 % confidence interval (CI), and a P value <0.05 was
considered statistically significant. All descriptive and
survival analyses were performed using SPSS for Windows,
version 21.0 (IBM, Armonk, NY, USA). R software (version
2.14.2) was used for PSM.
Results
Baseline characteristics of the subjects
The baseline characteristics of the 607 patients are listed
in Table 1. At CRRT initiation, the median patient age
was 73.0 years, and 60.1 % of the patients were male.
Before PSM, 303 patients were in the early CRRT
group, and 304 were in the late CRRT group. Sepsis
(45.3 %) was the most common cause of AKI, followed
by ischemia (18.5 %) and postoperative (9.7 %) and
nephrotoxic (7.4 %) causes. The median 6-h urine out-
put before CRRT initiation was 0.24 mL/kg/h. The pa-
tients were divided into two groups based on the median
6-hour urine output: early (≥0.24 mL/kg/h) and late
(<0.24 mL/kg/h) CRRT groups. The 6-hour urine vol-
umes before CRRT initiation were 230.0 (150.0–432.0)
mL in the early CRRT group and 20.0 (0.0–40.0) mL in
the late CRRT group. There was no difference in cumu-
lative fluid balance or diuretic use between the two
groups. The time from ICU admission to CRRT initi-
ation was 6.8 (1.5–31.1) h in the early CRRT group and
7.9 (1.7–37.8) h in the late CRRT group (P = 0.30). The
CCI, SOFA score, and APACHE II score did not differ
between the two groups. The number of patients
who required mechanical ventilation and the fraction
of inspired oxygen (0.5 (0.4-0.5) versus 0.5 (0.4–0.5),
P = 0.76) also did not differ between the two groups.
The systolic blood pressure (SBP) and mean arterial
pressure were higher in the early CRRT group. How-
ever, the target clearance and initial blood flow rate
for CRRT did not differ between the groups. The
serum creatinine level, eGFR, white blood cell count,
hemoglobin concentration, and platelet count also
did not differ between the groups. The prothrombin
time-international normalized ratio (PT-INR) and
serum total bilirubin, aspartate aminotransferase (AST),
and alanine aminotransferase (ALT) levels were higher in
the late CRRT group.
All of the patients in the two groups were matched by
propensity scores for the timing of initiation of CRRT
using the following covariates: age, sex, the CCI, SBP,
the PT-INR, and the total bilirubin level. After PSM, 482
patients (241 in each group) remained. The distributions
of the propensity scores before and after matching are
shown in the supplementary data section (Additional
file 1: Figure S1). Almost all of the baseline parame-
ters, including age, sex, body mass index (BMI), the
cause of AKI, time from ICU admission to CRRT ini-
tiation, the CCI, SOFA score, APACHE II score,
mechanical ventilation requirements, arterial pres-
sures, CRRT setting, and biochemical data, except for
the AST, ALT, and creatinine levels, were similar be-
tween the propensity score-matched patients in the
early and late CRRT groups. In addition, the propen-
sity scores of the matched patients did not differ be-
tween the groups.
Survival analyses stratified by timing of CRRT initiation
There were 490 mortalities (79.2 %) during the median
follow up of 9.6 days. Figure 1 shows the survival curves
obtained using the Kaplan-Meier method; these curves
were differentiated according to the body-weight-adjusted
median 6-h urine output. The early CRRT group had a
significantly higher cumulative survival rate than the late
CRRT group (P < 0.01), and increased survival after PSM
(P < 0.01). Univariate and multivariate Cox regression ana-
lyses were also performed (Table 2). Before PSM, in an un-
adjusted model the late CRRT group had an increased
hazard ratio (HR) for mortality (model 1: HR 1.60, 95 %
CI 1.33, 1.92, P < 0.01). This association was significant
after adjusting for age, sex, and the CCI (model 2: HR
1.60, 95 % CI 1.33, 1.91, P < 0.01) or for SBP, the PT-INR,
total bilirubin, AST, and ALT levels, cumulative fluid
balance and use of diuretics (model 3: HR 1.35, 95 %
CI 1.06, 1.71, P = 0.02). Furthermore, the association
remained significant after PSM (model 4: HR 1.32,
95 % CI 1.08, 1.61, P < 0.01). The 28-day cumulative
survival rate was higher in the early CRRT group
(Fig. 2, P < 0.01), and this trend also remained signifi-
cant after PSM (P = 0.01).
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Table 1 Baseline characteristics of the two groups stratified by median pre-CRRT 6-h urine output before and after propensity score matching at the time of CRRT initiation
Before propensity score matching After propensity score matching
Variable Early CRRT (N = 303) Late CRRT (N = 304) P value SD Early CRRT (N = 241) Late CRRT (N = 241) P value SD
Age (years) 75.1 (69.7–80.0) 74.0 (70.0–80.0) 0.80 −0.02 76.0 (70.2–80.6) 73.5 (69.5–80.0) 0.5 0.04
Sex, male (n (%)) 180 (59.4 %) 185 (60.9 %) 0.74 −0.01 145 (60.2 %) 145 (60.2 %) 1.00 0.03
Body mass index (kg/m2) 23.1 (20.1–25.8) 22.5 (20.0–25.0) 0.64 23.0 (20.2–25.6) 22.2 (19.7–25.0) 0.61
Cause of acute kidney injury (n (%)) 0.37 0.28
Septic 138 (45.5 %) 137 (45.1 %) 116 (48.1 %) 116 (48.1 %)
Nephrotoxic 27 (8.9 %) 18 (5.9 %) 20 (8.3 %) 12 (5.0 %)
Ischemic 49 (16.2 %) 63 (20.7 %) 37 (15.4 %) 46 (19.1 %)
Postoperative 34 (11.2 %) 25 (8.2 %) 26 (10.8 %) 21 (8.7 %)
Others 55 (18.2 %) 61 (20.1 %) 42 (17.4 %) 46 (19.1 %)
Time from ICU admission to CRRT initiation (h) 6.8 (1.5–31.1) 7.9 (1.7–37.8) 0.30 7.0 (1.6–32.0) 7.7 (1.6–32.1) 0.95
Charlson comorbidity index 7.0 (4.0–11.0) 5.0 (4.0–8.0) 0.23 −0.05 7.0 (4.0–11.0) 5.0 (4.0–8.0) 0.70 0.02
SOFA score 11.6 ± 3.7 12.5 ± 3.4 0.08 11.8 ± 3.6 12.4 ± 3.4 0.11
APACHE II score 28.5 ± 7.4 29.6 ± 7.1 0.19 29.2 ± 7.4 29.5 ± 7.1 0.65
Mechanical ventilation needs (n (%)) 251 (82.8 %) 253 (83.5 %) 0.78 203 (84.2 %) 200 (83.0 %) 0.60
FiO2 0.5 (0.4–0.5) 0.5 (0.4–0.5) 0.76 0.5 (0.4–0.5) 0.5 (0.4–0.5) 0.71
Systolic blood pressure (mmHg) 115.1 ± 24.7 109.3 ± 24.8 <0.01 0.31 111.9 ± 22.0 109.7 ± 24.7 0.30 0.08
Diastolic blood pressure (mmHg) 61.8 ± 14.0 61.0 ± 15.0 0.48 61.2 ± 13.1 61.8 ± 15.1 0.63
Mean arterial pressure (mmHg) 79.6 ± 15.6 77.1 ± 16.3 0.05 78.1 ± 14.1 77.8 ± 16.3 0.82
Six-hour urine volume before CRRT initiation (mL) 230.0 (150.0–432.0) 20.0 (0.0–40.0) <0.01 220.0 (147.5–420.0) 23.0 (0.0–43.8) <0.01
Cumulative fluid balance (mL) 1951.0 (424.8–3435.5) 2025.0 (0.0–4520.0) 0.06 1961.0 (544.5–3635.5) 2072.7 (0.0–4655.0) 0.37
Diuretics use (n (%)) 209 (69.0 %) 194 (63.8 %) 0.20 164 (68.0 %) 148 (61.4 %) 0.15
Target clearance (mL/kg/h) 40.0 (38.1–50.0) 40.0 (36.7–47.1) 0.88 40.0 (38.4–49.5) 40.0 (37.2–46.6) 0.70
Dialysate flow rate (mL/h) 1250.0 (1000.0–1550.0) 1100.0 (1000.0–1500.0) 0.23 1200.0 (1000.0–1500.0) 1100.0 (1000.0–1475.0) 0.34
Replacement flow rate (mL/h) 1200.0 (1000.0–1500.0) 1100.0 (1000.0–1500.0) 0.13 1200.0 (1000.0–1500.0) 1100.0 (1000.0–1475.0) 0.17
Blood flow rate (mL/min) 100.0 (100.0–100.0) 100.0 (100.0–100.0) 0.70 100.0 (100.0–100.0) 100.0 (100.0–100.0) 0.38
Biochemical data
White blood cells (n/μL) 12370.0 (7600.0–20500.0) 12975.0 (8495.0–24542.5) 0.11 12370.0 (7370.0–20570.0) 12975.0 (8500.0–24522.5) 0.06
Hemoglobin (g/dL) 9.7 (8.6–11.3) 9.4 (8.0–11.2) 0.38 9.8 (8.6–11.4) 9.4 (8.0–11.4) 0.76
Platelets (×103/μL) 104.0 (59.0–161.0) 96.0 (60.0–167.5) 0.42 98.0 (57.5–159.0) 96.0 (60.0–169.0) 0.68
PT-INR 1.4 (1.2–1.9) 1.7 (1.4–2.6) <0.01 −0.74 1.5 (1.2–2.0) 1.7 (1.3–2.4) 0.16 −0.22
Albumin (g/dL) 2.7 ± 0.5 2.7 ± 0.6 0.96 2.6 ± 0.5 2.7 ± 0.6 0.35
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Table 1 Baseline characteristics of the two groups stratified by median pre-CRRT 6-h urine output before and after propensity score matching at the time of CRRT initiation
(Continued)
Total bilirubin (mg/dL) 1.1 (0.8–.0) 1.6 (0.8–3.9) <0.01 −0.43 1.2 (0.8–2.2) 1.5 (0.8–3.3) 0.18 −0.08
Aspartate aminotransferase (IU/L) 68.0 (36.0–212.0) 198.5 (52.0–1049.8) <0.01 73.0 (36.0–254.5) 168.0 (47.3–1020.8) <0.01
Alanine aminotransferase (IU/L) 27.0 (16.0–117.0) 82.0 (19.0–379.0) <0.01 28.0 (16.0–126.5) 75.5 (19.0–347.5) <0.01
Blood urea nitrogen (mg/dL) 49.0 (35.0–71.0) 43.0 (32.0–65.5) 0.61 49.0 (33.0–69.0) 43.5 (32.0–63.5) 0.54
Creatinine (mg/dL) 2.8 (2.0–3.7) 2.7 (2.0–4.0) 0.07 2.7 (2.0–3.4) 2.7 (2.0–4.0) 0.01
The data are presented as the median (25-75th percentiles), mean ± standard deviation, or as number (percent). SD standardized difference, CRRT continuous renal replacement therapy, ICU intensive care unit, SOFA
sequential organ failure assessment, APACHE II acute physiology and chronic health evaluation II, FiO2 inspired oxygen fraction, PT-INR prothrombin time-international normalized ratio, eGFR estimated glomerular
filtration rate
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Duration of RRT and hospitalization
Before PSM, the durations of CRRT were 3.0 (0.9–6.1)
days in the early CRRT group and 2.4 (1.0–5.2) days
in the late CRRT group (P = 0.10) (Table 3). Although
the durations of total RRT (3.6 (1.1–10.7) versus 3.1
(1.1–9.6) days, P = 0.02) and ICU stay from CRRT initi-
ation (6.2 [1.8-11.4] versus 4.1 [1.4-9.3] days, P < 0.01)
were longer in the early CRRT group, there was no signifi-
cant differences in the duration of CRRT, total RRT, or
ICU stay among the survivors. While the duration of
hospitalization from CRRT initiation was longer in
the early CRRT group (16.5 (3.8–37.5) versus 6.1
(1.4–29.6) days, P < 0.01), it was shorter among the
survivors in this group (25.7 (16.5–38.6) versus 38.8
(27.2–79.3), P < 0.01).
After PSM, there was no significant difference in the
duration of CRRT or total RRT between all of the pa-
tients and the survivors. Although the duration of ICU
stay from CRRT initiation was longer in the early CRRT
group (6.2 (1.7–11.0) versus 3.9 (1.3–9.1), P = 0.02),
among the survivors there was no difference between
the groups. Further, while the total duration of
hospitalization did not differ between the groups, it was
shorter among the survivors in the early CRRT group
(26.7 (16.1–38.2) versus 39.1 (27.7–79.3) days, P = 0.04).
Discussion
In the present study, we compared the outcomes of
CRRT among elderly patients according to the timing of
CRRT initiation, with stratification by the median 6-h
urine output immediately before initiation, using pro-
spective data from 607 patients aged ≥65 years who
started CRRT due to AKI between 2009 and 2013 at
three centers. The results indicated a survival benefit of
early CRRT initiation.
The question of when to initiate dialysis in patients
with AKI has been debated almost as long as
hemodialysis has been an integral part of the treatment
of patients with AKI in clinical medicine. In general,
CRRT has been indicated for patients with severe AKI
presenting with intractable metabolic derangement or
uremic complications. Additionally, many factors must
be considered in deciding when to initiate CRRT, includ-
ing the patient’s demographic data, socio-economic status,
Fig. 1 Survival curves obtained using the Kaplan-Meier method for the cohort differentiated by the median 6-h urine output before (a) and after
(b) propensity score matching
Table 2 Multivariate analysis of risk factors for mortality in
elderly patients with severe acute kidney injury in the group
with late initiation of continuous renal replacement therapy
(CRRT) compared to the group with early initiation of CRRT
group, using Cox regression models and a propensity
score-matched model
Hazard ratio 95 % Confidence interval P value
Model 1a 1.60 1.33-1.92 <0.01
Model 2b 1.60 1.33-1.91 <0.01
Model 3c 1.35 1.06-1.71 0.02
Model 4d 1.32 1.08-1.61 <0.01
aUnadjusted. bAdjusted for age, sex, and the Charlson comorbidity index.
cAdjusted for age, sex, the Charlson comorbidity index, systolic blood pressure,
prothrombin time, total bilirubin, aspartate aminotransferase, alanine
aminotransferase, cumulative fluid balance and use of diuretics. dPropensity
score-matched; covariates for matching: age, sex, the Charlson comorbidity
index, systolic blood pressure, prothrombin time, and total bilirubin
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and clinical circumstances [8–10, 23]. Therefore, the opti-
mal timing of CRRT initiation has been difficult to
investigate and varies substantially among clinical
practitioners.
“Early” or “prophylactic” RRT was first introduced in
the 1950s. Early literature published in the 1960s and
1970s suggests that early initiation of RRT may improve
survival [24–30]. These studies defined early initiation of
dialysis as blood urea nitrogen (BUN) ranging from ap-
proximately <100 mg/dL to 150 mg/dL and late initi-
ation as BUN ranging from approximately 160 mg/dL to
>200 mg/dL. However, those studies had poor experi-
mental design, including inadequate, small sample sizes
and the use of arbitrary definitions for early initiation of
RRT. In one randomized controlled trial (RCT) that ana-
lyzed the outcomes of 34 patients with AKI in the
1980s, dialysis was performed to maintain predialysis
BUN at <60 mg/dL in an intensive treatment arm and at
100 mg/dL in a non-intensive arm [31]. Although
survival was lower in the intensively treated group, this
difference was not significant because of the small sam-
ple size.
In the late 1990s and early 2000s, several studies
evaluating the impact of the timing of CRRT initiation
also addressed the potential survival benefit of early dia-
lysis. Survival was better with early CRRT initiation
(39 % versus 20 %) in a study conducted in 1999, involv-
ing retrospective analysis of 100 patients who received
CRRT to treat post-traumatic AKI [32]. However, in this
study the definition of the timing of initiation of dialysis
was arbitrary and multivariate analysis was not per-
formed to correct for possible confounders, such as age
and serum albumin level. Similar data were reported in
the 2000s in three retrospective analyses of the timing of
CRRT initiation in patients following cardiac surgery
[33, 34] and in oliguric patients with sepsis [35]. In the
two former post-cardiac-surgery studies, oliguria,
defined as urine volume of <100 mL over 8 h despite
furosemide administration, was used as an initiation
criterion for early CRRT and azotemia (serum creatinine
>5 mg/dL [33] or BUN ≥84 mg/dL and serum creatinine
≥2.8 mg/dL [34]) and hyperkalemia (serum potassium
>5.5 mEq/L [33] or >6.0 mEq/L [34]) as a criterion for
late CRRT. Both studies demonstrated better survival in
the early dialysis group. In the latter study of patients
with oliguria and sepsis, there were also more favorable
survival outcomes in the group that with early initiation
of CRRT. Similar to many previous studies, BUN was
used in this study as a surrogate marker for the extent
of AKI. However, BUN is suboptimal for estimating
renal function because it is affected not only by glom-
erular filtration but also by renal tubular control, protein
intake, protein catabolism, various clinical conditions
(e.g., gastrointestinal bleeding), and pharmacological
therapy (e.g., corticosteroids) [36].
The timing of RRT in critically ill patients with AKI is
still the subject of controversy despite recent RCTs. Two
RCTs evaluating the effects of early versus late initiation
of RRT in critically ill patients with AKI have been pub-
lished in 2016 [37, 38]. One single-center RCT from
Fig. 2 Kaplan-Meier plots of cumulative 28-day survival stratified by the median 6-h urine output before (a) and after (b) propensity
score matching
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Table 3 Comparison of duration of dialysis and hospital stay before and after propensity score matching
Before propensity score matching After propensity score matching
All patients Survivors All patients Survivors
Characteristic Early CRRT
(N = 303)
Late CRRT
(N = 304)
P value Early CRRT
(N = 75)
Late CRRT
(N = 41)
P value Early CRRT
(N = 241)
Late CRRT
(N = 241)
P value Early CRRT
(N = 59)
Late CRRT
(N = 40)
P value
Duration of CRRT (days) 3.0 (0.9–6.1) 2.4 (1.0–5.2) 0.10 3.2 (2.1–6.3) 3.8 (2.4–6.9) 0.16 3.0 (0.9–6.6) 2.4 (0.8–5.1) 0.12 3.5 (2.5–6.8) 3.9 (2.4–6.9) 0.47
Duration of total RRT (days) 3.6 (1.1–10.7) 3.1 (1.1–9.6) 0.02 5.9 (2.3–12.9) 6.7 (3.7–27.4) 0.08 3.4 (1.0–10.2) 2.9 (1.0–9.4) 0.16 5.9 (3.0–11.3) 6.7 (4.2–27.4) 0.08
Duration of ICU stay from CRRT
initiation (days)
6.2 (1.8–11.4) 4.1 (1.4–9.3) <0.01 9.0 (4.8–19.8) 9.0 (5.0–19.9) 0.72 6.2 (1.7–11.0) 3.9 (1.3–9.1) 0.02 9.3 (4.9–18.5) 9.4 (5.5–19.9) 0.99
Total duration of hospitalization
from CRRT initiation (days)
16.5 (3.8–37.5) 6.1 (1.4–29.6) <0.01 25.7 (16.5–38.6) 38.8 (27.2–79.3) <0.01 15.5 (3.4–36.6) 6.1 (1.3–36.7) 0.08 26.7 (16.1–38.2) 39.1 (27.7–79.3) 0.04
The data are presented as the median (25-75th percentiles). CRRT continuous renal replacement therapy, RRT renal replacement therapy, ICU intensive care unit
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Germany included 231 critically ill patients with KDIGO
stage 2 AKI and plasma neutrophil gelatinase-associated
lipocalin (NGAL) >150 ng/Ml, and defined early RRT as
initiation within 8 h of diagnosis of stage 2 AKI and de-
layed RRT as initiation within 12 h of stage 3 AKI [37].
The researchers reported that early RRT initiation re-
duced mortality during the first 90 days.
Another multicenter RCT from France included 619
patients with severe AKI classified as KDIGO stage 3,
who required mechanical ventilation, catecholamine in-
fusion, or both, and did not have a potentially life-
threatening complication directly related to renal failure
[38]. The researchers defined early RRT as initiation im-
mediately after randomization and late RRT as initiation
in patients with at least one of the following criteria:
severe hyperkalemia, metabolic acidosis, pulmonary
edema, BUN > 112 mg/dL, and/or oliguria for more
than 72 h after randomization. They concluded that
there was no significant difference in 60-day mortality
between the early and late groups.
In the present study, we defined the elderly population
as individuals ≥65 years of age. Global life expectancy at
any age has increased, and the size of the population
above 65 years of age is rapidly increasing in developed
countries [39]. Along with the increasing size of the
elderly population, the incidence of AKI is also rising
[40–42]. Because of structural and functional changes in
the kidneys, the presence of multiple comorbidities, and
the resulting medication use, the elderly population is
less able to adapt to rapid hemodynamic changes and al-
terations in electrolyte levels and osmolality [1–5].
Moreover, as with other life-sustaining therapies, eco-
nomic and ethical concerns must be considered in mak-
ing decisions on the initiation of RRT in the elderly
population [43, 44].
According to previous studies involving intermittent
hemodialysis, elderly patients with AKI generally tolerate
hemodialysis well, despite their increased fragility [45].
Further, a critical care study has demonstrated that al-
though elderly individuals have increased mortality risk,
intensive care in this population is generally cost-effective
[44]. Although several previous studies have reported a
survival benefit of early CRRT in relatively older patients
with AKI [33, 46, 47], it does not seem appropriate to use
these data to predict the outcomes of elderly patients. In
2004, in two studies that included 64 and 61 AKI patients
who required CRRT after cardiac surgery respectively [33,
46], the conclusions was that early CRRT initiation is
beneficial. However, the ages of the patients in these stud-
ies were younger than in our study. In particular, the study
performed in Turkey included over 80 % of patients youn-
ger than 70 years of age [46], while 74 % of the partici-
pants in our study were over 70 years of age, and the
youngest patient was 65. Further, a study published in
2013 included patients with a mean age of 61 years. How-
ever, the standard deviation was relatively large, indicating
that most of the patients were under 65 years of age [47].
In addition, that study reported short-term outcome
(28-day survival) only. In contrast, we presented both
short-term and long-term outcomes, along with the
duration of CRRT, RRT, ICU stay and hospitalization,
which they did not report. Recently, a study published
in 2015, in which 32,045 patients were stratified be-
tween July 2000 and October 2008 according to the
KDIGO definition and classification of AKI, reported
that patients who met both the serum creatinine level
and urine output criteria for AKI were at the greatest
risk of death or RRT [48]. However, the researchers
investigated the outcomes of patients at various stages
of AKI (only approximately 30 % of the patients re-
quired RRT) and of those without AKI with a mean
age below 60 years. In contrast, we investigated the
outcomes of critically ill, elderly patients with a me-
dian age of approximately 75 years, who had severe
AKI and required CRRT.
In this study, we used the body-weight-adjusted me-
dian 6-h urine output immediately before CRRT initi-
ation as the criterion for CRRT initiation. The early
CRRT group had significantly better survival than the
late CRRT group, even after multivariate analyses of risk
factors. We chose the quantity of urine as a threshold
for CRRT initiation for several reasons. First, urine out-
put has long been used as a marker of AKI and for guid-
ing renal resuscitation in critically ill patients [49–52]. In
several previous studies urine output was also used as an
indication to start CRRT, with reported survival benefit
consistent with ours [33, 34, 46, 47]. Second, researchers
have questioned whether BUN is an appropriate bio-
marker for determining when to initiate dialysis [36].
Urine output markers other than BUN have been re-
ported to be potentially more suitable for prediction of
the survival of critically ill patients with AKI [31, 47].
One RCT conducted in 1986 reported that urine output
was a significant factor for survival. However, this study
did nto demonstrate the utility of BUN as an indicator
for starting dialysis [31]. A study performed in 2013 that
compared BUN and urine output as criteria for the tim-
ing of CRRT initiation in critically ill patients with AKI
concluded that urine quantity, but not the BUN concen-
tration, was significantly associated with prognosis [47].
Third, although some novel biomarkers have been re-
cently introduced as potentially better predictors of AKI,
their applicability as markers of severity remain limited
in clinical practice, especially in emergency departments
and ICUs.
Numerous studies have explored the utilization of
early biomarkers of AKI, such as NGAL and the recent
combination of tissue inhibitor of metalloproteinase-2
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and urine insulin-like growth factor-binding protein 7,
in critically ill patients during the last decade [53–59].
However, for critically ill patients with AKI, biomarkers
that reflect their ever-changing states are needed, and
there is limited time to wait for test results. Urine output
can be monitored very easily and allows for continuous
measurements. Therefore, it could be used as a general
tool for managing patients with AKI, including initial
screening, risk assessment, diagnosis, treatment deci-
sions, and assessment of prognosis. In our study, the
time from ICU admission to CRRT initiation did not sig-
nificantly differ between the groups (6.8 (1.5–31.1) hours
in the early CRRT group versus 7.9 (1.7–37.8) hours in
the late CRRT group, P = 0.30). This non-significant dif-
ference is in conflict with recent RCTs demonstrating
significant differences in the time from ICU admission
to RRT initiation [37, 38].
These discrepant results between our study and previ-
ous studies may be attributed to the use of different defi-
nitions of CRRT onset time [37, 38], in addition to
differences in clinical practice policies. A trend toward
admitting patients to the ICU at earlier time points
could have decreased the difference in the time between
CRRT initiation and ICU admission between the groups.
A previous study conducted at our institute demon-
strated that the time from ICU admission to CRRT initi-
ation did not significantly differ between patients with
high and low urine output at CRRT initiation, support-
ing the notion that institutional policy characteristics
may be partly responsible for our non-significant find-
ings [47].
To the best of our knowledge, this is the largest study
to show a survival benefit of early CRRT initiation in
critically ill, elderly patients with AKI. Our results were
obtained from a multicenter, prospective observational
study. Despite the increasing emphasis on the import-
ance of care for the elderly population and increase in
general medical management as care evolves, few studies
have specifically examined CRRT in older individuals.
Our data justify starting CRRT earlier in the course of
severe AKI in elderly patients. Although the worse out-
comes in the late CRRT group can be expected consider-
ing the univariate analysis results because of their lower
blood pressure and higher PT-INR, total bilirubin, AST
and ALT, the survival benefit of early CRRT initiation
remained, even after multivariate risk factor analyses
using the multivariate Cox regression model and PSM
with adjustments for significant factors for mortality.
We showed a significant survival benefit of early initi-
ation of CRRT in the elderly before and after PSM
(Figs. 1 and 2) and also demonstrated survival benefit in
multivariate analyses with adjustments for various fac-
tors that influence the survival of patients with AKI
(Table 2; model 3: HR 1.35, 95 % CI 1.06, 1.71, P = 0.02).
The adjusted factors that influence survival in univariate
analyses included age, sex, the CCI, SBP, prothrombin
time, the total bilirubin, AST, and ALT levels, cumula-
tive fluid balance, and use of diuretics. The significance
of these results was maintained even after comparison
with the propensity score-matched control group
(Table 2; model 4: HR 1.32, 95 % CI 1.08, 1.61, P < 0.01).
Additionally, on subgroup analysis of survivors, the total
duration of hospitalization from CRRT initiation was
shorter when CRRT was started earlier in the course of
AKI (Table 3; 26.7 (16.1–38.2) versus 39.1 (27.7–79.3)
days, P = 0.04). Although the duration of CRRT, total
RRT, and the ICU stay from the start of CRRT did not
differ based on the timing of CRRT initiation, our data
may be used to guide clinicians in making difficult deci-
sions about the management of critically ill, elderly pa-
tients with AKI.
Our study had several limitations. First, even after
adjusting for multiple confounders and selection effects,
subjects who possibly did not require CRRT may have
been included in the early initiation group. Second, the
quantity of urine is also an imperfect surrogate for renal
function. It is affected by not only glomerular filtration
but also volume status, urinary tract obstruction, and
pharmacological therapy. However, our aim was not to
find an indicator of kidney function but rather to iden-
tify a clinically useful marker that could predict the sur-
vival of patients with AKI. Third, our data are limited by
the definition of the timing of CRRT initiation. In this
study, urine output was the only variable that divided
the study population in terms of the timing of dialysis
initiation; several previous studies have used serum
creatinine [60] or BUN [31, 36, 47] as a marker along
with urine output. However, as stated previously, the
use of BUN has been challenged in many recent stud-
ies investigating the association between the timing of
dialysis initiation and mortality [36, 47], and to the
best of our knowledge, no study has assessed the su-
periority of serum creatinine over urine output as a
marker for determining the timing of dialysis initi-
ation. Fourth, because the arterial partial pressure of
oxygen was not known for the participants in this co-
hort, we were unable to determine the ratio of the ar-
terial oxygen concentration to the fraction of inspired
oxygen.
Conclusions
In conclusion, a better prognosis can be expected if
CRRT is applied early in the course of AKI in critically
ill, elderly patients. Although well-designed RCTs are
still necessary, our results contribute to the determin-
ation of whether early CRRT initiation yields a better
survival benefit in elderly patients with severe AKI.
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Additional file
Additional file 1: Figure S1. Distribution of propensity scores of the
patients before and after propensity score matching. The propensity
scores of the unmatched patients were significantly different between
the early and late CRRT groups. The propensity scores of the matched
patients were nearly identical between the two groups. (TIF 1300 kb)
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